SS-31 Specification and Vial Format Review walks through SS-31 (10mg / 50mg) documentation, vial format, and buyer workflow for Mitochondrial Research laboratories using sulanpeptide.vip.
SS-31, also known as Elamipretide, is a mitochondria-targeted tetrapeptide used in laboratory research on mitochondrial membrane models, cardiolipin-associated systems, oxidative-stress pathways, and peptide localization studies.
Seahorse XF mitochondrial stress tests, MitoSOX fluorescence, and cardiolipin peroxidation assays validate SS-31 mechanism studies. Steinhorn and Wallace group publications link elamipretide to Barth syndrome and heart failure mitochondrial rescue models in peer-reviewed cardiology research.
SS-31 (elamipretide) concentrates in inner mitochondrial membrane via cardiolipin interaction, stabilizing electron transport chain complex organization under oxidative stress. Research measures mitochondrial superoxide, ATP production, and cytochrome c retention in cardiomyocyte and skeletal muscle cell stress models.
Spec alignment: Enter exact strength notation (10mg / 50mg) in procurement systems—do not round kit counts. Side-by-side review of specification table, vial label, and COA prevents release errors for SS-31.
Principal investigators should sign off SS-31 SKUs only after mechanism fit is documented in the study protocol.
Catalog identifiers for SS-31: CAS 736992-21-5, Formula: C32H49N9O5. MW 639.79 g/mol, purity target ≥ 99.0%. Copy these fields into requisitions and match them line-by-line on incoming COA PDFs.
Publication methods should list Cat No. and mg strength for SS-31 to support reproducibility.
Dose planning for SS-31 should state mass (10mg / 50mg) or molarity derived from catalog molecular weight.
Side-by-side review of catalog specification table, quote confirmation, vial label, and COA prevents release errors for SS-31. QA sign-off should reference all four documents in the batch record. Purity target ≥ 99.0% on the catalog is a specification goal. Release criteria for SS-31 should state whether the lot COA must meet or exceed that threshold for your Mitochondrial Research assay type.
Specification alignment for SS-31 requires copying exact kit notation (10mg / 50mg) into ERP or LIMS systems. Rounding “10mg×10 vials” to “100mg total” causes mismatches when COA lists per-vial strength and suppliers ship multi-vial kits. Molecular identifiers for SS-31—CAS 736992-21-5, molecular weight, and formula when listed—should appear on internal sample labels alongside Cat No. Publications citing SS-31 should include these fields for reproducibility in Mitochondrial Research journals.
Format selection for SS-31 affects reconstitution math and aliquot planning. Compare available vial strengths on sulanpeptide.vip against protocol dose ranges before leadership approves a SKU; changing strength mid-study complicates comparability.
Molecular identifiers for SS-31—CAS 736992-21-5, molecular weight, and formula when listed—should appear on internal sample labels alongside Cat No. Publications citing SS-31 should include these fields for reproducibility in Mitochondrial Research journals. Format selection for SS-31 affects reconstitution math and aliquot planning. Compare available vial strengths on sulanpeptide.vip against protocol dose ranges before leadership approves a SKU; changing strength mid-study complicates comparability.
Specification alignment for SS-31 requires copying exact kit notation (10mg / 50mg) into ERP or LIMS systems. Rounding “10mg×10 vials” to “100mg total” causes mismatches when COA lists per-vial strength and suppliers ship multi-vial kits.
SS-31 from Sulan Peptide Official is for research use only (RUO)—not for human or veterinary use. Questions: Contact page or WhatsApp on sulanpeptide.vip.